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ABSTRACT
Qualitative analysis of lymphoscintigrams is subject to wide variability and may miss subtle differences in ilioinguinal uptake between 
normal and abnormal limbs. This study compared quantitative analysis to qualitative analysis of lower‑limb lymphoscintigraphy in diagnosing 
lymphedema. Fifty‑two lymphoscintigrams performed using standardized protocol, 99‑metastable technetium nanocolloid intradermal injection 
at the first interdigital space, were analyzed quantitatively. Fifty‑three normal and 51 abnormal limbs were analyzed. For each limb, a region of 
interest (ROI) was drawn around the injection site, and ilioinguinal nodes on the 1.5 h static images and the counts in these ROIs were recorded. 
Percentage ilioinguinal nodes uptake was then computed. Analysis of variance (ANOVA) was performed to determine the difference in ilioinguinal 
uptake between normal and abnormal limbs. Specificity and sensitivity were calculated and the figures were used to plot a receiver operator 
characteristic (ROC) curve. Thirty‑six females and 16 males (104 limbs) were analyzed. ANOVA revealed a significant difference between the 
mean uptake in normal (19.7%) and abnormal limbs (5.5%) (F = 81, P < 0.001). ROC had a maximal area under the curve of 0.924 (P < 0.001). 
The significant difference in the means of ilioinguinal uptake between normal and lymphedema limbs infers reduced lymphatic function. Ilioinguinal 
lymph node uptake is thus a reliable parameter in quantitative analysis of lymphoscintigrams.
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INTRODUCTION
Lymphedema is a painless, progressive accumulation of 
protein-rich fluid in the interstitial spaces of the skin, 
resulting from an anatomic or functional obstruction of the 
lymphatic system.[1,2] It is most common in the lower limbs, 
about 80% of cases, but can also occur in the arms, trunk, 
and external genitalia.
The primary pathology leading to lymphedema is dysfunction 
of the lymphatic transportation system.[3] Disruption of 
the lymphatic systems by pathological processes such 
as trauma, surgery and radiotherapy, infection, and 
congenital abnormalities can lead to lymphedema.[4] 
Primary lymphedema is usually as a result of congenital 
abnormalities in the lymphatic system which can be either 
aplasia or hypoplasia.[5,6] Lymphedema praecox is early-onset 
lymphedema, typically before 35 years. It is characterized 
by hypoplastic lymphatic system and is usually unilateral. 
Lymphedema tarda usually presents after 35 years of age, and 
there is much debate regarding its etiology. Milroy disease is 
the autosomal dominant form of typically bilateral primary 
lymphedema with the very early age of onset and is due to 
agenesis of the lymphatic system.[7]
Secondary lymphedema results from obstruction or 
interruption of the normal lymphatic channels. This can be 
iatrogenic (surgery and/or radiotherapy) or due to trauma or 
infections such as filariasis.[8]
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Lymphoscintigraphy is the primary imaging modality used in 
determining a diagnosis in patients with suspected extremity 
lymphedema.[5,6,9] The current protocol in our institution 
utilizes 20–40 mega-Becquerels (MBq) of 99-metastable 
technetium (Tc-99m) nanocolloid, injected intradermally, with 
static image acquisition at 5-min, 15-min, and 1.5-h intervals. 
Field of view is at the injection site on 5-min images and from 
the feet to the pelvis for the 15 minutes and 1.5 hour images. 
The patients walk for at least 5 min before the 15-min image.
Quantitative and semiquantitative analysis parameters can 
be used to complement visual analysis, to better characterize 
discrete changes, or to monitor therapeutic assessment in 
sequential studies.[10]
Quantitative parameters that can be assessed include the 
clearance of activity from the injection site, the fraction of 
the injected dose that accumulates in the draining lymph 
node groups, and the appearance of the radioactivity in the 
liver or blood.[3,11]
Quantitative analysis provides a means to unify the 
interpretation of scintigraphic findings, allowing for 
the detection of small changes in lymphatic function. 
Furthermore, the quantitative analysis can facilitate the 
comparison between studies during follow-up or after 
Figure 2: Lymphoscintigraphy image showing the regions of interest drawn 
around the injection site (A) and ilioinguinal nodes (B) for computation of 
ilioinguinal uptake 
Figure 3: Bar graph showing distribution of lymphedema by sex and side
Figure 4: Bar and whisker plot of uptake in lymphedema limbs and normal 
limbs
Figure  1:  1.5‑h  images  of  normal  (a  and  b)  and  abnormal  (c  and  d) 
lymphoscintigrams. 1.5‑h images of normal (a and b) and abnormal (c and d) 
lymphoscintigrams. (a and b), There is fairly uniform migration of tracer 
to the  ilioinguinal  lymph nodes.  (c) There  is dermal backflow in the  left 
lower limb, due to interruption of the lymphatic channels, and although 
not readily apparent, slightly less tracer reaches the left ilioinguinal nodes 
compared to the right; hence quantitative analysis would be of value in this 
case. (d) There is congenital aplasia of the lymphatic channels on the right 
and no tracer reaches the ilioinguinal nodes
dcba
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therapeutic interventions in a patient. Analysis by less 
experienced radiologists and nuclear physicians can be 
enhanced by quantitative analysis.
The data obtained would provide a more sensitive and 
reproducible approach to differentiate normal patients 
from those with mild lymphedema, more so for the less 
experienced radiologist.
MATERIALS AND METHODS
This was a prospective cross‑sectional study, in which 
consecutive patients undergoing lymphoscintigraphy at the 
Nuclear Medicine Department for suspected lymphedema, on 
the basis of unexplained lower‑limb swelling, were recruited.
Patients without images at 1.5 h were excluded from the 
study.
The sample size was calculated using the formula for studies 
comparing two means; the equation used for the sample size 
calculation is as follows:
2
crit pwr
2
4 ( + )
=
Z Z
N
D
σ
The study had a power of 80% and with 0.05 margin of error.
The estimated sample size was 102, 51 for the group with 
lymphedema and 51 for the group with normal limbs.
Patients were positioned supine and the Tc‑99m nanocolloid 
was injected intradermally to the first interdigital web of 
both limbs – if the dose was uneven, the larger dose was 
administered to the affected or more edematous limb. 
A static planar image of the feet with the entire injection 
site in the field of view was obtained 5‑min postinjection, 
on a 256 × 256 matrix. The patients were then asked to 
walk up and down the hallway 4–5 times (at least 2 min) 
and return back for 15‑min delay images. A hemi‑body 
planar image (starting from hip to feet) was obtained at 
15‑min and 1.5‑h postinjection, using a 256 × 1024 matrix.
Normal or abnormal limbs were selected on the basis 
of qualitative analysis by a consultant nuclear medicine 
physician with a 15‑year experience. Normal limbs showed 
Figure 5: Histograms showing distribution of percentage lymph node uptake
Figure 6: Q–Q plots showing distribution of ilioinguinal uptake in normal limbs and lymphedema limbs
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prompt and uniform migration of the radionuclide through 
discrete lymph vessels. Abnormal limbs had a combination 
of any of the following findings: interruption of lymphatic 
flow, collateral lymph vessels, progressive dermal backflow, 
delayed flow, delayed visualization or nonvisualization of 
lymph nodes, reduced number of lymph nodes, dilated 
lymphatics, and in severe cases no visualization of the 
lymphatic system at all [Figure 1].
For all the normal limbs, a region of interest was drawn 
around the injection site (B) and inguinal nodes (A) at 1.5-h 
static images [Figure 2]. Inguinal node uptake was computed 
as follows:
×100
( + )
A
A B
A similar analysis was done for the abnormal limbs.
Approval for the study was obtained from the institutional 
ethics review committee. All the study participants gave 
written informed consent. Consent was obtained from 
all the adult study participants and from the guardians of 
participants aged below 18 years.
This study portends no harm to the participants, and the 
standard imaging protocol was not altered. The study 
investigators have no conflict of interest to declare.
All statistical analysis was performed using SPSS version 17 
(SPSS Statistics for Windows, SPSS Inc: Chicago, USA).
RESULTS
Fifty-five bilateral lymphoscintigraphic examinations 
were performed between August 2014 and January 2015. 
Fifty-two patients (25 males and 26 females) were included 
in the final study. Excluded patients included one where 
1.5-h images were not acquired and two patients in whom 
both injection sites and ilioinguinal nodes were not in the 
field of view on the 1.5-h images. The median age was 
37.5 years, with a standard deviation (SD) of 19.7; their mean 
duration of lymphedema was at least 5.5 years [Table 1].
The proportion of males with positive scans (diagnosis of 
lymphedema) was significantly higher (78% vs. 36% P < 0.001). 
Both limbs were equally affected with lymphedema, with no 
preference for either side [Figure 3 and Table 2].
Quantitative analysis
The mean for each of the groups is illustrated in [Table 3 
and Figure 4].
The data were skewed to the right in both the normal group 
and the group with lymphedema [Figure 5]. The Kolmogorov–
Smirnov test for normality, however, showed a lognormal 
distribution which is a common finding in many biologic 
samples [Figure 6].
Analysis of variance
Following analysis of variance (ANOVA), the difference 
of the means between the two groups was statistically 
significant (P ≤ 0.0001). An F value (a measure of 
intergroup vs. intragroup variance) of 81.37 indicates a 
large difference.
Table 1: Demographic characteristics of the subjects
n Minimum Maximum Mean Median SD
Age of subject 
(years)
52 3 90 37.9 37.5 19.7
Age at onset of 
edema (years)
52 0 70.0 32.3 30 17.1
Duration of 
edema (years)
52 0 30 5.5 3 7.0
SD: Standard deviation
Table 2: Distribution of lymphedema by sex
Sex Outcome (/limb) Total
Lymphedema Normal
Male 25 7 32
Female 26 46 72
Total 51 53 104
Table 3: Ilioinguinal lymph node uptake among normal and 
lymphedema limbs
Outcome n Mean (%) SD SEM
Ilioinguinal node uptake
Lymphedema 51 5.5 4.8 0.7
Normal 53 19.7 10.2 1.4
SD: Standard deviation; SEM: Standard error of mean
Figure 7: Receiver operator characteristic curve
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Receiver operator characteristics
Using different cutoffs of percentage ilioinguinal uptake, 
specificity and sensitivity were calculated, and the 
values obtained were used to plot a receiver operator 
characteristic (ROC) curve [Figure 7]. Area under the 
curve (AUC) was also estimated. AUC was 0.924.
The cutoff value giving the best trade-off between 
sensitivity and specificity (highest and most to the left) is 
9.74 (sensitivity = 86.8%, specificity = 82.4%).
DISCUSSION
The study sample consisted of 36 females and 16 males. The 
mean age of the population was 37.9 years, with a range from 
3 to 90 years. It was noted that most patients presented in 
their 30s to 40s, which perhaps represents patients with 
lymphedema tarda.
Secondary lower-limb lymphedema is not common in our 
setting. This is in sharp contrast to studies in Europe and 
Asia where secondary causes predominate.
The average onset of lymphedema was 32 years. This could 
be partly explained by lymphedema tarda which prior authors 
have given as onset of lymphedema after 35 years.[12] The 
patients whose onset of edema was between puberty and 
30 years represent patients with lymphedema praecox. 
A small number of patients with congenital lymphedema 
presented before puberty.
The average duration of edema at the time of presentation 
was 5.4 years (0–30 years). The fact that most patients 
sought intervention after a mean duration of 5 years may 
reflect onset of other clinical symptoms besides edema or 
worsening edema.
Following qualitative lymphoscintigraphy, only one male 
patient had a normal examination while the rest had either 
unilateral (5 subjects) or bilateral lymphedema (10 subjects). 
In contrast, 16 females had normal limbs, while 14 had 
unilateral lymphedema and six had bilateral lymphedema. 
The proportion of males with positive scans was significantly 
higher (78% vs. 36% P = 0.000). This suggests that edema of 
whatever etiology may be more common in females, while 
edema in males is more likely to be lymphedema. Most other 
studies have indicated a higher incidence of lymphedema 
among females. Indeed, some causes of lower-limb swelling 
such as lipedema are exclusive to women.[13] Obesity which is 
a recognized risk factor for lymphedema[14] is more common 
in females. In a study by Dalia et al., a total of 77 patients 
(66 women, 11 men) were studied.[15] Of these, 21 patients 
had unilateral extremity involvement and 56 had bilateral 
lymphedema. It seems that unilateral lymphedema is more 
common in our population.
Among the patients with unilateral edema, there was a 
trend toward more involvement of the left limb. The level 
of physical activity aids in lymphatic clearance, and most 
people in the general population are right-handed, which 
may partially explain the higher number of abnormal left 
limbs, but this may be further investigated with more robust 
research. On quantitative analysis of ilioinguinal lymph node 
uptake, the limbs with lymphedema had reduced uptake: 
mean 5.5, SD 4.8. Normal limbs had significantly higher 
ilioinguinal uptake values and a large SD of 10.1. A statistically 
significant difference between the means of the two groups 
was observed after ANOVA. F statistic of 81 indicates a large 
difference between the two means. The data described in 
this study are compatible with that in the literature, showing 
reduced ilioinguinal lymph node accumulation of radiotracer 
in lymphedema.[15,16]
Using qualitative lymphoscintigraphy as the reference 
standard, sensitivity and specificity for each ilioinguinal 
uptake value were computed and an ROC curve was 
plotted. The AUC was 0.924 (P < 0.001). This indicates that 
quantitative analysis is an accurate tool in the diagnosis of 
lymphedema.
By selecting an ilioinguinal node uptake of 9.7%, lymphedema 
could be diagnosed with 86.8% sensitivity and 82.4% specificity. 
When lymphatic dysfunction is bilateral, quantification of 
lymph node accumulation and clearance of activity from 
the injection site both become important parameters. 
Again, it should be emphasized that these parameters are 
strongly influenced by the amount of exercise a patient 
can perform.[17] In addition, the uptake index can be used 
to monitor progression of disease as well as response to 
therapeutic measures.
CONCLUSION
Ilioinguinal lymph node uptake can be used for the 
differentiation of normal l imbs from l imbs with 
lymphedema. Quantitative analysis if developed and 
standardized can be an accurate tool in the diagnosis 
of lymphedema. Quantitative indices would be useful 
for monitoring of disease progression and efficacy of 
therapeutic measures.
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